SHELL ASSET MANAGEMENT CO - BLUEPRINT MEDICINES CORP ownership

BLUEPRINT MEDICINES CORP's ticker is BPMC and the CUSIP is 09627Y109. A total of 278 filers reported holding BLUEPRINT MEDICINES CORP in Q2 2021. The put-call ratio across all filers is 1.50 and the average weighting 0.2%.

Quarter-by-quarter ownership
SHELL ASSET MANAGEMENT CO ownership history of BLUEPRINT MEDICINES CORP
ValueSharesWeighting
Q4 2022$195
-99.9%
4,448
-16.9%
0.01%
-35.7%
Q3 2022$353,000
+3.5%
5,351
-20.8%
0.01%
+40.0%
Q2 2022$341,000
-20.9%
6,755
+0.1%
0.01%0.0%
Q1 2022$431,000
-48.0%
6,745
-12.9%
0.01%
-41.2%
Q4 2021$829,000
+4.5%
7,744
+0.4%
0.02%
-5.6%
Q3 2021$793,000
+12.2%
7,713
-4.1%
0.02%
+28.6%
Q2 2021$707,000
-4.3%
8,043
+5.8%
0.01%
-6.7%
Q1 2021$739,000
+41.8%
7,603
+63.5%
0.02%
+36.4%
Q4 2020$521,000
+42.3%
4,649
+17.6%
0.01%
+22.2%
Q3 2020$366,000
+18.8%
3,9520.0%0.01%
+12.5%
Q2 2020$308,000
+30.5%
3,952
-2.2%
0.01%
+14.3%
Q1 2020$236,000
-28.3%
4,039
-1.5%
0.01%0.0%
Q4 2019$329,000
+5.8%
4,101
-3.1%
0.01%0.0%
Q3 2019$311,000
-22.8%
4,231
-0.9%
0.01%
-22.2%
Q2 2019$403,000
+15.5%
4,268
-2.2%
0.01%
+12.5%
Q1 2019$349,000
+48.5%
4,3660.0%0.01%
+33.3%
Q4 2018$235,000
-36.8%
4,366
-8.4%
0.01%
-14.3%
Q3 2018$372,000
+22.8%
4,7660.0%0.01%
+16.7%
Q2 2018$303,000
-34.4%
4,766
-5.3%
0.01%
-33.3%
Q1 2018$462,000
+21.6%
5,0350.0%0.01%
+12.5%
Q4 2017$380,0005,0350.01%
Other shareholders
BLUEPRINT MEDICINES CORP shareholders Q2 2021
NameSharesValueWeighting ↓
Aquilo Capital Management, LLC 581,768$25,487,2569.57%
Casdin Capital, LLC 1,477,800$64,742,4185.02%
Nextech Invest Ltd. 188,228$8,246,2693.28%
DAFNA Capital Management LLC 261,235$11,444,7053.22%
Rock Springs Capital Management LP 1,891,510$82,867,0531.99%
HealthCor Management, L.P. 30,000$1,314,3001.20%
EFG Asset Management (North America) Corp. 110,853$4,766,6791.07%
Novo Holdings A/S 370,000$16,209,7001.01%
SECTORAL ASSET MANAGEMENT INC 115,900$5,077,5790.98%
EMERALD MUTUAL FUND ADVISERS TRUST 305,709$13,393,1110.83%
View complete list of BLUEPRINT MEDICINES CORP shareholders